Zhejiang Jianfeng Group Co., Ltd.

Equities

600668

CNE000000B18

Construction Materials

End-of-day quote Shanghai S.E. 23:00:00 14/05/2024 BST 5-day change 1st Jan Change
9.1 CNY -0.33% Intraday chart for Zhejiang Jianfeng Group Co., Ltd. +0.33% -17.65%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug MT
Jianfeng Group's Pharma Unit Gets Nod to Sell Glaucoma Eye Drops MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Zhejiang Jianfeng Unit's Gastroesophageal Reflux Drug Chosen for China's Centralized Procurement MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Jianfeng Group's Pharmaceutical Unit Gets US FDA's Nod to Trial Lung Cancer Drug MT
Zhejiang Jianfeng's Unit Gets Nod to Make Changes to Mycophenolate Mofetil Capsules MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhejiang Jianfeng Registers Valsartan Amlodipine Tablet in China MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Production Line of Zhejiang Jianfeng's Pharma Unit Passes Regulatory Inspection MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Three Chinese Drugmakers Deny Receiving Orders From Pfizer MT
Zhejiang Jianfeng Group Co., Ltd.(XSSC:600668) dropped from S&P Global BMI Index CI
Xinjiang Tianshan Cement Raises $14.7 Billion From Private Share Sale MT
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Xinjiang Tianshan Cement Co., Ltd. completed the acquisition of stakes in South West Cement Company Limited and South Cement Company Limited from a group of sellers. CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Zhejiang Jianfeng Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Chart Zhejiang Jianfeng Group Co., Ltd.
More charts
ZHE JIANG JIAN FENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture and distribution of cement and pharmaceuticals. The Company mainly conducts its cement business in Hubei Province, Yunnan Province, Zhejiang Province and Guangxi Province. The Company provides pharmaceuticals, including anti-infective drugs, antipyretic and analgesic drugs, drugs for cardiovascular system diseases, drugs for diabetes mellitus, bulk drugs, intermediates and over the counter (OTC) products. The Company is also engaged in the provision of health products, and the manufacture and distribution of cables. The Company conducts its business in domestic markets.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. 600668 Stock
  4. News Zhejiang Jianfeng Group Co., Ltd.
  5. Production Line of Zhejiang Jianfeng's Pharma Unit Passes Regulatory Inspection